High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer. (Q43897506)
Jump to navigation
Jump to search
scientific article published on 4 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer. |
scientific article published on 4 December 2013 |
Statements
High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer (English)
Nicole Rotmensz
Aron Goldhirsch
Carmen Criscitiello
Davide Disalvatore
Lucia Gelao
Luca Fumagalli
Marzia Locatelli
Vincenzo Bagnardi
Angela Esposito
Ida Minchella
Sabino De Placido